Prof. Dr. med. Nicole Reisch
Medizinische Klinik IV
Klinikum der Universität München
Ludwig-Maximilians-Universität München
Ziemsstraße 5
80336 München
Email: | nicole.reisch(at)med.uni-muenchen.de |
Phone: | +49 89 4400-52110 |
Publikationen
M.
Auer,
A.
Nordenstrom,
S.
Lajic, and
N.
Reisch,
Congenital adrenal hyperplasia, Lancet , vol. 401, no. 10372, pp. 227-244, 2023.
Congenital adrenal hyperplasia, Lancet , vol. 401, no. 10372, pp. 227-244, 2023.
DOI: | 10.1016/S0140-6736(22)01330-7 |
N. Reisch,
Block and Replace-a New Therapeutic Concept in Congenital Adrenal Hyperplasia?, J Clin Endocrinol Metab , vol. 107, no. 1, pp. e423-e425, 2022.
Block and Replace-a New Therapeutic Concept in Congenital Adrenal Hyperplasia?, J Clin Endocrinol Metab , vol. 107, no. 1, pp. e423-e425, 2022.
DOI: | 10.1210/clinem/dgab555 |
H.
Grinten,
P.
Speiser,
S.
Ahmed,
W.
Arlt,
R.
Auchus,
H.
Falhammar,
C.
Fluck,
L.
Guasti,
A.
Huebner,
B.
Kortmann,
N.
Krone,
D.
Merke,
W.
Miller,
A.
Nordenstrom,
N.
Reisch,
D.
Sandberg,
N.
Stikkelbroeck,
P.
Touraine,
A.
Utari,
S.
Wudy, and
P.
White,
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management, Endocr Rev , vol. 43, no. 1, pp. 91-159, 2022.
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management, Endocr Rev , vol. 43, no. 1, pp. 91-159, 2022.
DOI: | 10.1210/endrev/bnab016 |
M.
Auer,
L.
Paizoni,
M.
Neuner,
C.
Lottspeich,
H.
Schmidt,
M.
Bidlingmaier,
J.
Hawley,
B.
Keevil, and
N.
Reisch,
11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia, J Steroid Biochem Mol Biol , vol. 212, pp. 105921, 2021.
11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia, J Steroid Biochem Mol Biol , vol. 212, pp. 105921, 2021.
DOI: | 10.1016/j.jsbmb.2021.105921 |
V.
Stachanow,
U.
Neumann,
O.
Blankenstein,
U.
Fuhr,
W.
Huisinga,
R.
Michelet,
N.
Reisch, and
C.
Kloft,
Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling, Eur J Endocrinol , vol. 185, no. 3, pp. 365-374, 2021.
Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling, Eur J Endocrinol , vol. 185, no. 3, pp. 365-374, 2021.
DOI: | 10.1530/EJE-21-0395 |
H.
Nowotny,
M.
Auer,
C.
Lottspeich,
H.
Schmidt,
I.
Dubinski,
M.
Bidlingmaier,
J.
Adaway,
J.
Hawley,
B.
Keevil, and
N.
Reisch,
Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia, J Clin Endocrinol Metab , vol. 106, no. 11, pp. e4509-e4519, 2021.
Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia, J Clin Endocrinol Metab , vol. 106, no. 11, pp. e4509-e4519, 2021.
DOI: | 10.1210/clinem/dgab446 |
L.
Paizoni,
M.
Auer,
H.
Schmidt,
A.
Hubner,
M.
Bidlingmaier, and
N.
Reisch,
Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Steroid Biochem Mol Biol , vol. 197, pp. 105540, 2020.
Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Steroid Biochem Mol Biol , vol. 197, pp. 105540, 2020.
DOI: | 10.1016/j.jsbmb.2019.105540 |
M.
Auer,
L.
Paizoni,
L.
Hofbauer,
M.
Rauner,
Y.
Chen,
H.
Schmidt,
A.
Huebner,
M.
Bidlingmaier, and
N.
Reisch,
Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency, J Steroid Biochem Mol Biol , vol. 204, pp. 105734, 2020.
Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency, J Steroid Biochem Mol Biol , vol. 204, pp. 105734, 2020.
DOI: | 10.1016/j.jsbmb.2020.105734 |
M.
Auer,
A.
Krumbholz,
M.
Bidlingmaier,
D.
Thieme, and
N.
Reisch,
Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, Neuroendocrinology , vol. 110, no. 11-12, pp. 938-949, 2020.
Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency, Neuroendocrinology , vol. 110, no. 11-12, pp. 938-949, 2020.
DOI: | 10.1159/000504672 |
N.
Reisch,
A.
Taylor,
E.
Nogueira,
D.
Asby,
V.
Dhir,
A.
Berry,
N.
Krone,
R.
Auchus,
C.
Shackleton,
N.
Hanley, and
W.
Arlt,
Alternative pathway androgen biosynthesis and human fetal female virilization, Proc Natl Acad Sci U S A , vol. 116, no. 44, pp. 22294-22299, 2019.
Alternative pathway androgen biosynthesis and human fetal female virilization, Proc Natl Acad Sci U S A , vol. 116, no. 44, pp. 22294-22299, 2019.
DOI: | 10.1073/pnas.1906623116 |
- Mitglieder
- Leitung
- SFB 1665 Office
- Projektleiter*innen
- Aherrahrou, Redouane
- Busch, Hauke
- Frielitz-Wagner, Isabel
- Göpel, Wolfgang
- Hiort, Olaf
- Holterhus, Paul-Martin
- Hornig, Nadine
- Hundt, Jennifer E.
- Jürgensen, Martina
- Kircher, Martin
- König, Inke R.
- Krämer, Ulrike
- Kulle, Alexandra
- Laudes, Matthias
- Mangold, Anna Katharina
- Malich, Lisa
- Mittag, Jens
- Müller, Franz-Josef
- Nemec, Birgit
- Palm, Kerstin
- Rehmann-Sutter, Christoph
- Reisch, Nicole
- Seeger, Karsten
- Spielmann, Malte
- Stammberger, Birgit
- Stoff, Heiko
- Postdoktorand*innen
- Doktorand*innen
- Ärzt*innen
- Koordinator*innen
- Technisches Personal
- Beteiligte Universitäten, Institute und Kliniken